Kent, OH, United States of America

Songping D Huang

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: Kent State University, Case Western Reserve University. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Songping D Huang. Retrieved from https://idiyas.com/inventor/songping-d-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Songping D Huang

Introduction

Songping D Huang is a notable inventor based in Kent, OH (US), recognized for his significant contributions to the field of antimicrobial agents and MRI contrast materials. With a total of 5 patents, Huang has made strides in developing innovative solutions to combat drug-resistant infections and enhance medical imaging techniques.

Latest Patents

One of Huang's latest patents focuses on rationally designed lawsone derivatives as antimicrobials against multidrug-resistant bacteria. Naphthoquinone derivatives of lawsone have shown effectiveness against methicillin-resistant Staphylococcus aureus (MRSA). These compounds typically feature a substituent group at the 3-position of a specific naphthoquinone compound, such as 2-hydroxy-1,4-naphthoquinone. Notably, one derivative, referred to as compound 6c, exhibits potent antimicrobial activity comparable to the commercial antibiotics ofloxacin and ciprofloxacin against methicillin-sensitive strains. Furthermore, compound 6c demonstrates remarkable efficacy against MRSA strains that have developed resistance to both ofloxacin and ciprofloxacin, rivaling the effectiveness of vancomycin and daptomycin. Additionally, 6c has shown effectiveness against vancomycin-intermediate and daptomycin non-susceptible strains of MRSA, boasting an improved drug resistance profile compared to conventional antibiotics.

Another significant patent involves the development of nanoparticulate manganese MRI contrast agents. This invention outlines a synthetic procedure for preparing nanoparticulate materials of various metal cyanide compounds containing manganese(II) ions in the crystal lattice. These materials are coated with a hydrophilic compound and serve as MRI contrast agents with high sensitivity, long blood circulation half-lives, and low toxicity in both low-field and high-field MRI scanners.

Career Highlights

Huang has worked with esteemed institutions such as Kent State University and Case Western Reserve University, where he has contributed to research and development in his areas of expertise. His work has not only advanced scientific knowledge but has also paved the way for practical applications in medicine.

Collaborations

Huang has collaborated with notable colleagues, including Yongxiu Li and Mohammadreza Shokouhimehr, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Songping D Huang's innovative

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…